Perioperative Treatment with Rivaroxaban and Dabigatran on Changes of Coagulation and Platelet Activation Biomarkers following Left Atrial Appendage Closure
Insufficient data exist regarding the investigation of the impact of novel oral anticoagulants (NOACs) on coagulation activation biomarkers in the context of left atrial appendage closure (LAAC) and device-related thrombosis (DRT). The study was designed to investigate the changes and presence of co...
Saved in:
Main Authors: | Yao Yao, Yanli Li, Qinchun Jin, Xiaoye Li, Xiaochun Zhang, Qianzhou Lv |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/2024/4405152 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful Resolution of a Large Left Atrial and Left Atrial Appendage Thrombus with Rivaroxaban
by: Safwan Gaznabi, et al.
Published: (2019-01-01) -
Cerebral Embolic Protection in Patients Undergoing Left Atrial Appendage Closure
by: Julia Seeger, et al.
Published: (2024-12-01) -
Combined Catheter Ablation and Left Atrial Appendage Closure in Atrial Fibrillation Patients with and without Prior Stroke
by: Bin-Feng Mo, et al.
Published: (2021-01-01) -
Left Atrial Appendage Closure for Stroke Prevention in Patients with Atrial Fibrillation and Hereditary Hemorrhagic Telangiectasia
by: Sebastiaan Velthuis, et al.
Published: (2012-01-01) -
Long-Term Safety and Efficacy of Percutaneous Left Atrial Appendage Closure with the LAmbre Device
by: Guangji Wang, et al.
Published: (2020-01-01)